Saturday 27 June 2015

Global Cardiac Prosthetic Devices Market Challenges, Trends and Forecasts, 2015-2019

Global Cardiac Prosthetic Devices Market 2015-2019 is a new market research publication announced by Reportstack. Prosthetic devices are used to replace or support the function of a missing or infirm part in the body. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, which reduces due to blockage in the arteries, whereas prosthetic heart valves are being used by patient with heart valvular disease or dysfunctional heart valve. 
The analysts forecast that the global cardiac prosthetic market to grow at a CAGR of 8.41% over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac prosthetic market for the period 2015-2019. The market can be segmented into two based on products: prosthetic heart valves and coronary stents.
The report, the Global Cardiac Prosthetic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global cardiac prosthetic market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas 
• APAC
• EMEA 
Key vendors
• Boston Scientific 
• Edwards Lifesciences
• Medtronic
• Sorin Group
• St. Jude Medical
Other prominent vendors
  • AorTech International 
    • Abbott Vascular
    • Accellent
    • Admedes Schuessler
    • Alvimedica
    • Arbor Surgical
    • B. Braun Melsungen 
    • Biosensors International 
    • Biotronik
    • Boston Scientific
    • Bracco AMT 
    • Colibri Heart Valve
    • Elixir Medical 
    • eucatech
    • Eurocor 
    • Hexacath 
    • InspireMD
    • InSitu Technologies
    • iVascular
    • LEPU MEDICAL
    • Meril Life Sciences 
    • Merit Medical
    • OrbusNeich
    • QT Vascular
    • Rontis 
    • SCITECH
    • Shanghai MicroPort Scientific 
    • STENTYS
    • Svelte Medical Systems
    • Symetis
    • Translumina
    Market driver
    • Rise in birth prevalence of congenital heart disease worldwide
    • For a full, detailed list, view our report
    Market challenge
    • Risk of complications and re-interventions
    • For a full, detailed list, view our report
    Market trend
    • Increase in use of low-profile stents grafts for aneurysm repair
    • For a full, detailed list, view our report
    Key questions answered in this report
    • What will the market size be in 2018 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

  • Companies Mentioned
    Boston Scientific, Edwards Lifesciences, Medtronic, Sorin Group,St. Jude Medical, AorTech International, Abbott Vascular, Accellent, Admedes Schuessler, Alvimedica, Arbor Surgical, B. Braun Melsungen, Biosensors International, Biotronik, Boston Scientific, Bracco AMT, Colibri Heart Valve, Elixir Medical, eucatech, Eurocor, Hexacath, InspireMD, InSitu Technologies, iVascular, LEPU MEDICAL, Meril Life Sciences, Merit Medical, OrbusNeich, QT Vascular, Rontis, SCITECH, Shanghai MicroPort Scientific, STENTYS, Svelte Medical Systems, Symetis, Translumina
    Contact:
    Debora White
    Manager - Marketing 
    debora@reportstack.com
    Ph: +1-888-789-6604
    Reportstack Market Research
    ###

    No comments:

    Post a Comment